For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260429:nRSc3839Ca&default-theme=true
RNS Number : 3839C European Metals Holdings Limited 29 April 2026
Proposed Issue of Securities
European Metals Holdings Limited (ASX and AIM: EMH, OTCQX: EMHXY and EMHLF)
("European Metals" or the "Company") advises that it is seeking shareholder
approval at the Company's Annual General Meeting scheduled to be held on
Friday, 29 May 2026 ("Meeting") to issue a total of 3,600,000 performance
rights to Directors Keith Coughlan and Richard Pavlik, as per an ASX lodgement
made by the Company today -
https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-03084046-6A1322831&v=undefined
(https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-03084046-6A1322831&v=undefined)
.
The Company will provide an update following the Meeting regarding the issue
of performance rights.
ENDS
CONTACT
For further information on this update or the Company generally, please visit
our website at www.europeanmet.com (http://www.europeanmet.com) or see full
contact details at the end of this release.
ENQUIRIES:
European Metals Holdings Limited
Keith Coughlan, Executive Chairman Tel: +61 (0) 419 996 333
Email: keith@europeanmet.com (mailto:keith@europeanmet.com)
Kiran Morzaria, Non-Executive Director Tel: +44 (0) 20 7440 0647
Carly Terzanidis, Company Secretary Tel: +61 8 6245 2050
Email: cosec@europeanmet.com (mailto:cosec@europeanmet.com)
Zeus Capital Limited (Nomad & Broker)
James Joyce/Darshan Patel/Chris Wardley Tel: +44 (0) 203 829 5000
(Investment Banking)
Harry Ansell (Broking)
BlytheRay (Financial PR)
Tim Blythe Tel: +44 (0) 20 7138 3222
Megan Ray
Chapter 1 Advisors (Financial PR - Aus)
David Tasker Tel: +61 (0) 433 112 936
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END MSCPPUQPCUPQUMB
Copyright 2019 Regulatory News Service, all rights reserved